We use cookies for a better user experience. Read our Privacy Policy

I Agree

Hospital-acquired Pneumonia Prevention Market

Hospital-acquired Pneumonia Prevention Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Hospital-acquired Pneumonia Prevention Market: Introduction

  • Demand to prevent hospital-acquired pneumonia has been rising due to an increase in focus on maintaining high standards of hygiene across hospitals. Pneumonia is a serious disease that results in inflation of the lungs due to inflow of excessive fluid. Pneumonia can affect one or both of the lungs, and can majorly affect regular breathing. Pneumonia can be prevented through vaccination; however, the chances of acquiring it cannot be eliminated. Therefore, it is important to take proper steps to prevent pneumonia from spreading, especially across hospitals. The contagious nature of the disease increases the risk of acquiring pneumonia from hospitals and other public areas. It is extremely important to immunize hospitals and healthcare centers from contagious diseases such as pneumonia. Several new medically-approved procedures have been developed to prevent the spread of hospital-acquired pneumonia. Moreover, doctors and medical professionals have also been emphasizing on the development of healthy and congenial surroundings across healthcare centers.
  • The global market for hospital-acquired pneumonia prevention can be segmented based on product type, end-user, and region. The forces operating in the global hospital-acquired pneumonia prevention market can be understood by analyzing these segments.

Key Drivers, Restrains, and Opportunities of Global Hospital-acquired Pneumonia Prevention Market

  • Numerous patients suffering from pneumonia remain hospitalized for long duration. Hence, the risk of acquiring pneumonia for a healthy person is much greater across hospitals and healthcare centers. The need to take necessary steps to prevent the spread of pneumonia through hospitals is significantly high. Therefore, the global market for hospital-acquired pneumonia prevention has been expanding significantly for the last decade. Advancements in the field of hygiene and health across public spaces is another key factor driving the global market for hospital-acquired pneumonia prevention.
  • Educational campaigns aimed at generating awareness about health and hygiene are estimated to further fuel the market. Stipulation of key standards to be followed across hospitals is another factor that has propelled the market. Investments made toward improving medical standards across the world have also boosted the market.
  • Governments of developing countries are making significant investments to modernize their respective healthcare infrastructure, which is likely to increase access to healthcare. This is expected to increase the demand for hospital-acquired pneumonia prevention. Increase in prevalence of chronic diseases in developing countries presents lucrative opportunities to the global hospital-acquired pneumonia prevention market.

North America to Capture Major Share of Global Hospital-acquired Pneumonia Prevention Market

  • In terms of region, the global market for hospital-acquired pneumonia prevention can be segmented into Latin America, North America, the Middle East & Africa, Europe, and Asia Pacific. The market for hospital-acquired pneumonia prevention in North America has been expanding due to advancements in the field of hospital hygiene and care.
  • North America is expected to account for a major share of the global hospital-acquired pneumonia prevention market due to high prevalence of chronic diseases among the population in the region. Moreover, well-established healthcare infrastructure and hub for key industry players are major drivers of the hospital-acquired pneumonia prevention market in the region.
  • The hospital-acquired pneumonia prevention market in Asia Pacific is projected to expand at a rapid pace during the forecast period owing to a rise in healthcare infrastructure. Moreover, a surge in the geriatric population coupled with chronic diseases is likely to further propel the market in the region.

Key Players Operating in Global Hospital-acquired Pneumonia Prevention Market

The global hospital-acquired pneumonia prevention market is highly concentrated due to the presence of key players. A large number of manufacturers hold a major share in their respective regions. Demand for products to treat chronic diseases has increased in emerging as well as developed markets. Growth strategies adopted by leading players are likely to drive the global hospital-acquired pneumonia prevention market.

Major players operating in the global hospital-acquired pneumonia prevention market are listed below:

  • Halyard Health, Inc.
  • Intersurgical Ltd.
  • Medline Industries, Inc.
  • Sage Products LLC (Stryker Corporation)

Global Hospital-Acquired Pneumonia Prevention Market: Research Scope

Global Hospital-Acquired Pneumonia Prevention Market, by Product Type

  • Oral Care Kit
  • Toothbrush
  • Swab
  • Moisturizer
  • Mouth Wash
  • Suction Tools

Global Hospital-Acquired Pneumonia Prevention Market, by End-user

  • Hospitals
  • Rehabilitation Centers
  • Home Care Settings

Global Hospital-Acquired Pneumonia Prevention Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Interested in this report?
Get a FREE Brochure now!

Request Brochure

*Get Brochure (PDF) sent to your email within minutes

N/A

Transparency Market Research Plus

Get a free copy if the report you purchased is updated within 90 days

Copyright © Transparency Market Research, Inc. All Rights reserved